Navigation Links
Meditrina Pharmaceuticals, Inc. Opens Investigational New Drug (IND) Application for Phase IIb Clinical Trial With MPI-676 in Endometriosis
Date:7/17/2008

- Approval of Second IND Marks Major Corporate Milestone and Advances

Clinical Program -

ANN ARBOR, Mich., July 17 /PRNewswire/ -- Meditrina Pharmaceuticals, Inc. today announced the approval of its second investigational new drug (IND) application for a Phase IIb dose ranging clinical trial to study MPI-676, the Company's aromatase inhibitor (AI), in combination with estrogen and progestin for the treatment of endometriosis. MPI-676 is the newest addition to Meditrina's clinical stage product portfolio that currently includes Femathina(TM) (MPI-674), an AI that Meditrina is repurposing for the treatment of endometrial thinning prior to endometrial ablations in premenopausal women with abnormal uterine bleeding. Meditrina recently completed a global licensing agreement to make, develop and commercialize products, including MPI-676, under AstraZeneca's IP and know-how regarding the use of AIs in combination with estrogen and progestin to treat endometriosis.

"This IND for MPI-676 marks another major milestone in our robust clinical program focused on addressing women's reproductive system disorders," said James Symons, Ph.D., Vice President, Clinical Development, Meditrina Pharmaceuticals, Inc. "Based on the encouraging proof of concept and strong safety data established for MPI-676, we look forward to selecting the dose for Phase III pivotal trials, which will be at a dose lower than for which AstraZeneca has already established two-year chronic use safety data in their breast cancer prevention trials and is cited in the anastrozole product label. These data will advance development of MPI-676 and help us bring this important new treatment to women suffering from endometriosis, a painful and debilitating condition."

This US-based, multi-center, placebo-controlled, double-blinded study will identify the maximally efficacious dose of MPI-676 to investigate in the pivotal Phase III program. The Phase IIb dose ra
'/>"/>

SOURCE Meditrina Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Keryx Biopharmaceuticals, Inc. Announces Phase 2 Results on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Waldenstroms Macroglobulinemia at the 44th Annual Meeting of the American Society of Clinical Oncology
2. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
3. Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois
4. Jazz Pharmaceuticals, Inc. Completes Enrollment in First of Two Phase III Clinical Trials of Sodium Oxybate to Treat Fibromyalgia
5. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
6. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
7. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
8. Jazz Pharmaceuticals, Inc. Announces Receipt of FDA Orphan Drug Designation for Recurrent Acute Repetitive Seizures Product Candidate
9. Solvay Pharmaceuticals, Inc. Responds to Advisory Committee Recommendation for Further Study of Tedisamil to Treat Atrial Fibrillation
10. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
11. Quark Pharmaceuticals, Inc. Announces First Systemic siRNA Dosing in Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... July 30, 2014  InnoPharma, Inc. today announced the ... generic equivalent of Zyprexa® injection), in Canada.  Olanzapine is ... behaviors in patients with schizophrenia or bipolar I mania. ... drug, InnoPharma has entered into an agreement with Sandoz ... will make, use, sell, market and distribute Olanzapine Injection ...
(Date:7/30/2014)... and PARIS , July 30, ... ) and Sanofi (EURONEXT: SAN and NYSE: ... ODYSSEY trials of alirocumab in people with hypercholesterolemia met ... from baseline in low-density lipoprotein cholesterol (LDL-C) at 24 ... an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... products for oncology supportive care, announced that its novel ... featured in an article on OncLive.com titled, "Study Finds ... Neck Cancers."  Dr. Steve Sonis , a leading ... demand seen in the oncology community for evidence-based strategies ...
Breaking Medicine Technology:InnoPharma Announces Launch of Olanzapine for Injection, 10mg/vial in Canada 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 2Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 3Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 4Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 5Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 6Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 7Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia 8Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3
... /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ("Golden Meditech," 0801.HK, ... Bon International") today announced that the companies have ... strategic cooperation in Taipei.  Golden Meditech Holdings Chairman, ... International, Mr. Chu Powei, respectively represented and co-chaired ...
... BRUNSWICK, N.J., and LEIDEN, Netherlands, Feb. 17, 2011 ... (NYSE Euronext, Nasdaq: CRXL ; Swiss Exchange: CRX) today ... to acquire Crucell N.V. (Crucell) has been satisfied.  The initial offering ... a.m. New York time) on 16 February 2011.   ...
Cached Medicine Technology:Golden Meditech to Form Strategic Alliance with Long Bon International 2Golden Meditech to Form Strategic Alliance with Long Bon International 3Minimum Acceptance Condition Satisfied 2Minimum Acceptance Condition Satisfied 3Minimum Acceptance Condition Satisfied 4Minimum Acceptance Condition Satisfied 5Minimum Acceptance Condition Satisfied 6
(Date:7/30/2014)... 2014 Calling all runners in the Richmond, ... it will host a monthly Runner’s Injury Clinic ... Brick Road the second Monday of each month through the ... 13, November 10 and December 8. , The clinics ... should wear running shoes and attire, will receive a complimentary ...
(Date:7/30/2014)... (PRWEB) July 31, 2014 WalkingSticksandCane.com ... Walking Canes. The ladies will love the new European fashions ... Sticks . These sticks and canes are from one from ... England. Each of the styles re unique and offer the ... , The Blackthorn Walking Sticks are some of the rarest ...
(Date:7/30/2014)... Daily Gossip indicates in its 60 Second Panic Solution ... is a feeling of intense stress and fear, which may ... symptoms that sufferers commonly deal with when panic attacks are ... anxiety. Naturally, panic attacks deeply affect lifestyle; this is why ... , The 60 Second Panic Solution review promises to be ...
(Date:7/30/2014)... Daily Gossip mentions that the "Panic Away" method ... to stop anxiety and eliminate all associated symptoms. It has ... than 150,000 people in getting their lives back. , The ... treatment system that will teach sufferers different techniques on how ... simple to access, as it is available in a complex ...
(Date:7/30/2014)... 30, 2014 Serial entrepreneur, Paul Mata, spent ... millions. However, like most people, in 2008 he suffered extreme ... a better way, Paul carefully studied the difference between people ... do not. Based on the knowledge he acquired, he was ... his life and health, but also grow his clients' personal ...
Breaking Medicine News(10 mins):Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 2Health News:Tidewater Physical Therapy to Host Monthly Runner’s Injury Clinic at 3 Sports Glen Allen Location 3Health News:European Walking Sticks from WalkingSticksandCane.com 2Health News:60 Second Panic Solution Review Reveals Unique Way to Stop Panic Attacks 2Health News:Panic Away Review Reveals How to Stop Anxiety 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 2Health News:Paul Mata Kicks off 3-day Wealth Bootcamp on September 11th 3
... , , , , , WALTHAM, ... of the world,s leading research and advisory firms focusing on pharmaceutical ... averaged 40 percent less than U.S. prices in 2008. Within Europe ... prices in Italy to 70 percent of U.S. prices in Germany. ...
... Bear Naked, the natural foods innovator, announced today that it is ... of granola bars that offer active consumers a unique, on-the-go snacking alternative ... and available in three enticing flavors--Chocolaty Cherry, Tropical and Fruit and Nut-- ... & Na tu ral ...
... glaucoma , TUESDAY, July 7 (HealthDay News) -- A ... cerebral infarcts could help explain the medical mystery of ... the progressive loss of vision caused by deterioration of ... to the brain. It is customarily attributed to abnormally ...
... July 7 /PRNewswire-FirstCall/ - SXC Health Solutions Corp. ("SXC" ... SXC), a leading provider of technology and pharmacy benefit ... has been awarded an 18-month contract, with an option ... Presbyterian Health Plan, a health maintenance organization (HMO) based ...
... 7 "It,s time for Plaintiffs, attorneys to do ... we are making that happen," says Stephen Ambrose, CIO ... is a startup healthcare IT company which utilizes Collaborative ... as a request for a patient,s health record. This ...
... ... fitness, to attract and retain good talent. However, Freightquote took this industry initiative one ... mental health, financial wellbeing, and education. , ... Lenexa, KS (PRWEB) July 7, 2009 -- Freightquote.com ...
Cached Medicine News:Health News:European Prices of 170 Best-Selling Drugs Averaged 40 Percent Less Than U.S. Prices in 2008 2Health News:Bear Naked Introduces All Natural Granola Bars 2Health News:Mini-Strokes May Cause Vision Loss 2Health News:Mini-Strokes May Cause Vision Loss 3Health News:SXC Health Solutions announces PBM contract with Presbyterian Health Plan 2Health News:SXC Health Solutions announces PBM contract with Presbyterian Health Plan 3Health News:SXC Health Solutions announces PBM contract with Presbyterian Health Plan 4Health News:New Software Makes Lawyers Accountable for Their Part in Our Healthcare Crisis 2Health News:Freightquote.com Encourages Healthy Lifestyle, FreightFit Changes Lives 2Health News:Freightquote.com Encourages Healthy Lifestyle, FreightFit Changes Lives 3
... Finnpipette BioControl multichannel has ... as the single channel ... fits allseven multichannel and ... cone modules. Both pipettes ...
... and best value in high performance electronic ... ultra lightweight design reduce hand fatigue and ... lever tip ejector , Color coding for ... or for greater performance use Hamilton AdvanTip ...
... pro Electronic Pipette is ideal for all ... easy-to-follow display, ergonomically-placed operating buttons, and various ... pipetting and diluting make this a lab ... of a manual pipette without any adverse ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
Medicine Products: